摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to application of 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol in free form or in form of pharmaceutically acceptable salt (FTY720) for treatment of autoimmune disease of disorder, where dose of FTY720 during initial period of 4 days constitutes 0.5 mg/1 mg/1.5mg/2 mg, respectively, where after that treatment is continued with day dose equal 0.5 mg.EFFECT: invention relates to set, containing day units of drug forms of 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol in free form or in form of pharmaceutically acceptable salt (FTY720) for treatment of autoimmune disease of disorder.5 cl |